Ann Belien
Founder and CEO at Rejuvenate Biomed | Hasselt, Flemish Region, Belgium
Ann Belien’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
ContactOut Insights • AI Generated
Ann Belien serves as the Founder and CEO of Rejuvenate Biomed, a clinical-stage biopharmaceutical company headquartered in Hasselt, Belgium, where she directs efforts to translate fundamental aging research into therapeutic interventions. She leverages her educational background from ETH Zürich to oversee the development of oral combination therapies targeting the biology of aging through proprietary platforms like CombinAge® and CelegAge®. Under her leadership, the company has advanced its lead program, RJx-01, which demonstrated safety, efficacy, and a disease-modifying mechanism in human sarcopenia trials ahead of scheduled Phase 2b data release.
BEST APPROACH TO REACH Ann Belien
Contact Ann primarily via personal email with a targeted message detailing how your offering streamlines AI-powered compound screening or de-risks late-stage geroscience trials to request a brief introductory call.
Founder and CEO at Rejuvenate Biomed in October 2017 - Present
Campus Strategy and Open Innovation at The Janssen Pharmaceutical Companies of Johnson & Johnson in January 2017 - September 2017
R&D head of Strategy and External Innovation, Janssen Prevention Center at Janssen, Pharmaceutical Companies of Johnson and Johnson in January 2012 - December 2016
Integration Crucell, Project Management Office Lead at Janssen, Pharmaceutical Companies of Johnson and Johnson in December 2010 - December 2011
Strategic Officer, Tibotec at Janssen, Pharmaceutical Companies of Johnson and Johnson in December 2009 - December 2010
Project Management Leader Early Development, Tibotec at Janssen, Pharmaceutical Companies of Johnson and Johnson in May 2007 - August 2010
Preclinical, Pharmaceutical, Clinical development & regulatory PM, Late development at The Janssen Pharmaceutical Companies of Johnson & Johnson in June 2003 - May 2007
Scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson in April 2000 - April 2003
ETH Zürich, Post-doc, July 1999 to July 2026
University of Zurich, PhD, July 1995 to July 1999
Vrije Universiteit Brussel, Masters, July 1992 to July 1995
Rejuvenate Biomed is a clinical-stage biopharmaceutical company developing differentiated oral combination therapies targeting the biology of aging. Its lead program, RJx-01, has demonstrated safety, efficacy, and a disease-modifying mechanism in human sarcopenia studies, with Phase 2b data expected end 2026. The company’s CombinAge® (AI platform) and CelegAge® (in vitro platform), enables rapid identification of synergistic, clinically translatable combinations. This approach has led to a pipeline of compounds currently in pre-clinical development.
Discover more about Rejuvenate Biomed
Senior Pharma R&D Leader | Discovery & Clinical Development | Clinical Translational Science | Biomarkers | Team Leadership
Managing Director at ADQ - Consulting in Life Sciences Research & Drug Development
(Dec 2023 – Present)
Pharma R&D Leader | Clinical & Translational Sciences | Drug Discovery & Development
o Leading the Clinical & Translational Science strategy to drive the development of first-in-human and early clinical studies for age-related disease programs.
o Overseeing biomarker strategy, clinical assay development, and mechanistic readouts across preclinical and clinical...
Clinical Operations Lead at Rejuvenate Biomed
Clinical Operations Lead at Rejuvenate Biomed
(May 2023 – Present)
Head of ICT
Head of ICT at Rejuvenate Biomed
(Nov 2024 – Present)
Scientific Lead
Scientific Lead at Rejuvenate Biomed
(Feb 2025 – Present)
Chief Scientific Officer at Rejuvenate Biomed
Chief Scientific Officer at Rejuvenate Biomed
(Jan 2019 – Present)
What is Ann Belien email address?
Email Ann Belien at [email protected] and [email protected]. This email is the most updated Ann Belien's email found in 2026.
How to contact Ann Belien?
To contact Ann Belien send an email to [email protected] or [email protected]. (updated on November 08, 2025)
What company does Ann Belien work for?
Ann Belien works for Rejuvenate Biomed.
What is Ann Belien's role at Rejuvenate Biomed?
Ann Belien is Founder and CEO
What industry does Ann Belien work in?
Ann Belien works in the Pharmaceuticals industry.
